Metabolite pathway | Protocol 1 | |||||
---|---|---|---|---|---|---|
 | Name | HMDB ID | Placebo | 7.5 mg | 15 mg | 30 mg |
Proteogenic amino acids | L-glutamine | HMDB00641 | 0.9 | 1.5** | 4.1* | 3.3*** |
 | L-histidine | HMDB00177 | 1.2 | 0.8 | 1.3 | 2.3** |
 | L-asparagine | HMDB00168 | 0.9 | 1.1** | 1.3** | 1.6*** |
 | L-alanine | HMDB00161 | 1.0 | 1.0 | 1.3 | 1.6*** |
 | L-threonine | HMDB00167 | 0.9 | 0.9 | 1.0* | 1.4*** |
 | L-tryptophan | HMDB00929 | 1.0 | 1.1 | 1.1 | 1.3*** |
 | L-serine | HMDB00187 | 1.0 | 0.9 | 1.0 | 1.2* |
 | L-isoleucine | HMDB00172 | 1.2 | 0.9 | 0.9** | 1.3 |
Other amino acids | Kynurenate | HMDB00715 | 1.1 | 0.9 | 0.8*** | 0.9** |
 | Prolyl-4-hydroxyproline | HMDB06695 | 1.1 | 1.1 | 0.8** | 0.8** |
Carbohydrate metabolism | D-glucose | HMDB00122 | 1.2 | 1.4 | 1.4 | 5.5* |
 | Gluconate | HMDB00625 | 1.3 | 1.1 | 1.0** | 0.9*** |
 | N-acetylgalactosamine-4-sulfate | HMDB00781 | 1.2 | 1.0 | 0.9 | 0.8*** |
 | Sorbitol | HMDB00247 | 1.2 | 1.0 | 0.9* | 0.8* |
Steroids | Dehydroepiandrosterone sulfate | HMDB01032 | 0.9 | 0.2*** | 0.2** | 0.2*** |
Energy metabolism | Isocitrate | HMDB00193 | 1.1 | 1.1 | 0.9* | 0.8*** |
 | Phosphate | HMDB01429 | 1.1 | 1.0 | 0.8* | 0.8** |
 | Citrate | HMDB00094 | 1.4 | 1.0* | 1.0** | 0.7*** |
Nucleotide metabolism | Nicotinic acid mononucleotide | HMDB01132 | 1.4 | 1.3 | 1.0* | 0.9* |
 | Pseudouridine | HMDB00767 | 1.1 | 1.0 | 1.0 | 0.9* |
 | N-methylnicotinamide | HMDB00699 | 1.2 | 0.9 | 0.6* | 0.5** |
Vitamins and cofactors | Pyridoxine | HMDB00239 | 1.2 | 0.7** | 0.7 | 0.8** |
Xenobiotics | Mandelic acid | HMDB00703 | 1.0 | 1.1 | 1.0 | 1.4** |
 | Salicyluric acid | HMDB00840 | 2.5 | 1.3 | 1.0** | 1.0 |
 | Tartaric acid | HMDB00956 | 1.1 | 1.1 | 0.9* | 0.9 |
Catecholamine metabolism | Homovanillic acid | HMDB00118 | 1.2 | 0.9* | 0.9** | 1.0* |
 | Dopamine | HMDB00073 | 1.3 | 0.9** | 0.8*** | 0.9** |
 | Vanillylmandelic acid | HMDB00291 | 1.1 | 1.0 | 0.9 | 0.9* |
Glycerophospholipid metabolism | Ethanolamine | HMDB00149 | 1.0 | 0.8** | 0.8** | 0.9* |